Pfizer Inc (HAM:PFE)
€ 21.16 -0.67 (-3.07%) Market Cap: 123.30 Bil Enterprise Value: 167.89 Bil PE Ratio: 18.87 PB Ratio: 1.56 GF Score: 74/100

Q1 2026 Pfizer Inc Earnings Call Transcript

May 05, 2026 / 02:00PM GMT
Release Date Price: €22.32 (-1.06%)
Operator

Good day, everyone, and welcome to Pfizer's first quarter 2026 earnings conference call. Today's call is being recorded.

At this time, I would like to turn the call over to Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am.

Francesca DeMartino
Pfizer Inc - Senior Vice President, Chief Investor Relations Officer

Good morning and welcome to Pfizer's earnings call. I'm Francesca DeMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us. This call is being made available via audio webcast at pfizer.com.

Earlier this morning, we released our results for the first quarter 2026 via press release that is available on our website at pfizer.com. I'm joined today by Dr. Albert Bourla, our Chairman and CEO; and Dave Denton, our CFO. Albert and Dave have some prepared remarks, and we will then open the call for questions. Members of our leadership team will be available for the Q&A session.

Before we get started, I want to remind you that we will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot